Previous Blogs

Stoppers and Plungers

By Olga Laskina, Ph.D.

七月 10, 2020

The overall quality of a final drug product depends on the components of its packaging and delivery systems.  The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.

SmartDose Delivery Platform

By Frederike Ferber

三月 12, 2018

Biologic drug products are not new – their development began decades ago; the first monoclonal antibody was commercialized in 1986. [1] With the increasing availability of genetic information, and better understanding of subcellular cascades and disease processes, the number of biologic drug products available has increased substantially in response to an exponential growth in targets. [2]

The SmartDose Platform in use

By Fran DeGrazio

四月 05, 2017

Industry meetings continue to reinforce the changing landscape of the drug pipeline and the influence of biologic drug products in driving this change.  At the recent DCAT Week, hosted by the Drug, Chemical and Associated Technologies Association, Josef Bossart, of PharmaCircle, provided an excellent overview of historic trends and current forecasts.